Aethlon Medical
- Country
- Ownership
- -
- Employees
- 14
- Market Cap
- -
- Introduction
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device
- Conditions
- COVID-19
- Interventions
- Device: Hemopurifier
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Aethlon Medical Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT04595903
- Locations
- 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
🇺🇸LSU Health Sciences Center, Shreveport, Louisiana, United States
🇺🇸Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
Hemopurifier Plus Pembrolizumab in Head and Neck Cancer
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- Device: Hemopurifier
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Aethlon Medical Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT04453046
- Locations
- 🇺🇸
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Safety Study of the Aethlon Hemopurifier
- Conditions
- End Stage Renal DiseaseHepatitis C Infection
- Interventions
- Device: Affinity plasmapheresis
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Aethlon Medical Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02215902
- Locations
- 🇺🇸
DaVita Med Center Dialysis, Houston, Texas, United States